San Diego, CA, United States of America

Alan S Krasner

This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Crinetics Pharmaceuticals, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alan S Krasner. Retrieved from https://idiyas.com/inventor/alan-s-krasner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alan S. Krasner: Innovator in Medical Treatments

Introduction

Alan S. Krasner is a notable inventor based in San Diego, CA. He has made significant contributions to the field of medicine, particularly in the treatment of diseases related to ACTH excess. His innovative work has led to the development of a patent that addresses critical health issues.

Latest Patents

Alan S. Krasner holds a patent for a Melanocortin subtype-2 receptor (MC2R) antagonist aimed at treating diseases such as Cushing's disease, ectopic ACTH syndrome, and congenital adrenal hyperplasia. This patent represents a breakthrough in therapeutic methods and compositions for managing these conditions. He has 1 patent to his name.

Career Highlights

Krasner is currently associated with Crinetics Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work at the company focuses on innovative solutions for endocrine disorders, showcasing his commitment to improving patient outcomes.

Collaborations

One of his notable collaborators is Christine Ferrara-Cook, with whom he has worked closely to further their research initiatives. Their partnership exemplifies the collaborative spirit in the scientific community.

Conclusion

Alan S. Krasner's contributions to medical science through his patent and work at Crinetics Pharmaceuticals, Inc. highlight his role as an innovator in the treatment of serious health conditions. His dedication to advancing medical treatments continues to make a significant impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…